Cisco Systems, Inc. (NASDAQ:CSCO) belongs to Technology sector. Its net profit margin is 18.30% and weekly performance is -0.18%. On last trading day company shares ended up $27.28. Cisco Systems, Inc. (NASDAQ:CSCO) distance from 50-day simple moving average (SMA50) is -4.35%. Cisco Systems, Inc. (NASDAQ:CSCO) said that it will invest $1 billion in the United Kingdom over the next three to five years, including money for startups in the Internet of Things.
Independent Bank Group, Inc. (NASDAQ:IBTX) shares increased 2.47% in last trading session and ended the day at $43.63. Its return on assets is 1.00%. Independent Bank Group, Inc. (NASDAQ:IBTX) quarterly performance is 10.52%. Independent Bank Group, Inc. (NASDAQ:IBTX) will hold a conference call to discuss second quarter results on Tuesday, July 28, 2015 at 8:30 am EDT. The related press release will be issued Monday, July 27, 2015 at 5:00 pm EDT.
On 10 July, Qiagen NV (NASDAQ:QGEN) shares increased 4.04% and was closed at $25.73. QGEN EPS growth in last 5 year was -5.60%. Qiagen NV (NASDAQ:QGEN) year to date (YTD) performance is 9.68%. Seegene Inc. (KOSDAQ: 096530) announced that it has entered into a worldwide collaboration agreement with Qiagen NV (NASDAQ:QGEN) to develop and supply molecular diagnostic assays.
Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM) ended the last trading day at $25.12. Company weekly volatility is calculated as 2.23% and price to cash ratio as 10.05. Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM) showed a weekly performance of -3.27%. Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM) Aloha United Way added eight new members to its 27-member board of directors last week, including Scott Barber, the new CEO ofHawaiian
, and retired attorney and Hawaiian Electric IndustriesChairman Jeff Watanabe.
Pfizer Inc. (NYSE:PFE) shares increased 1.48% in last trading session and ended the day at $34.36. PFE Gross Margin is 81.00% and its return on assets is 6.80%. Pfizer Inc. (NYSE:PFE) quarterly performance is -2.25%. Pfizer Inc. (NYSE:PFE) and the Jeffrey Modell Foundation (JMF) announced a collaboration agreement to conduct research in the field of immunological diseases. CTI and JMF will identify and co-fund translational research projects with leading academic medical centers within the CTI network. The goal of each research project will be to identify and validate a potential drug candidate for an immunological disease that can be moved into further clinical testing.